Ani Pharmaceuticals (ANIP) Invested Capital (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Invested Capital of $19.3 million for Q1 2026, up 11.76% sequentially from $17.3 million in Q4 2025, and up 72.41% YoY from $11.2 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Invested Capital (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Invested Capital for 11 years, with the latest figure at $19.3 million in Q1 2026.
- Quarterly Invested Capital rose 72.41% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.3 million (up 132.51% YoY) and the FY2025 annual result came in at $17.3 million, up 88.27% from the prior year.
- Invested Capital rose to $19.3 million in Q1 2026 per ANIP's latest filing, from $17.3 million in the prior quarter.
- Over five years, Invested Capital peaked at $346.9 million in Q1 2022 and troughed at $414000.0 in Q1 2024.
- A 5-year average of $105.3 million and a median of $12.3 million in 2023 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2025: Invested Capital plunged 99.88% in 2024, then jumped 2603.62% in 2025.
- Over 5 years, Invested Capital stood at $338.5 million in 2022, then plunged by 96.38% to $12.3 million in 2023, then slipped by 25.22% to $9.2 million in 2024, then jumped by 88.27% to $17.3 million in 2025, then grew by 11.76% to $19.3 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $19.3 million, $17.3 million, and $15.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 630.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | 21.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.33 Mn |
| Mar 31, 2026 | 19.30 Mn |
| Dec 31, 2025 | 17.27 Mn |
| Sep 30, 2025 | 15.24 Mn |
| Jun 30, 2025 | 483,000.00 |
| Mar 31, 2025 | 11.19 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 841,000.00 |
| Mar 31, 2024 | 414,000.00 |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 850,000.00 |
| Jun 30, 2023 | 850,000.00 |
| Mar 31, 2023 | 340.33 Mn |
| Dec 31, 2022 | 338.54 Mn |
| Sep 30, 2022 | 337.53 Mn |
| Jun 30, 2022 | 337.81 Mn |
| Mar 31, 2022 | 346.94 Mn |
| Dec 31, 2021 | 359.59 Mn |
| Sep 30, 2021 | 207.33 Mn |